Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    These changes are minor UI/text updates, including glossary toggle labels (Show glossary / Hide glossary) and footer/versioning text (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-22T17:45:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears on the page, replacing the previous Revision: v3.3.3. This is a metadata version update and does not alter study details, results, or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-01-15T10:51:01.000Z thumbnail image
  4. Check
    48 days ago
    Change Detected
    Summary
    Locations section updated with a revised global list of study sites across multiple regions (e.g., U.S. states, Australia, Canada, Europe, and others). This corresponds to Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T21:49:28.000Z thumbnail image
  5. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:57:15.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Removed the generic government funding status notice about data recency and operations. The study details on the page remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-19T08:42:43.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, outcomes, and locations appear unchanged; the observed differences seem limited to cosmetic or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:19:45.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.